Frequently, tumor-infiltrating specific CTLs are exhausted and express high levels of inhibitory immune checkpoint (ICP) molecules, including PD-L1, which bind to their ligands on tumor cells (PD-L1) and inactivate the ability of T cells to reject tumors [52]. This evidence concerns the gene CD274 and neoplasm.